Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash $ 255,615 $ 1,479,166
Prepaid expenses 6,995 7,995
Inventory 121,994 121,994
Current Assets 384,604 1,609,155
Fixed Assets, net of accumulated depreciation 3,939,894 3,763,332
Other Assets 610,764 529,863
TOTAL ASSETS 4,935,262 5,902,350
Current Liabilities    
Accounts payable and accrued liabilities 852,394 804,138
Notes payable, net of discount 906,432 700,015
Contingent stock liability 847,000 677,000
Contingent warrant liability 702,000 585,000
Total Current Liabilities 3,307,826 2,766,153
Commitments and Contingencies (Notes 5 and 13) Subsequent Events (Note 14)
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 1 share issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 5,187,062 shares issued and outstanding 2022 and 2021 519 519
Common stock subscription receivable (32,500)
Additional paid-in capital 14,164,342 13,835,882
Accumulated deficit (12,537,425) (10,667,704)
Total Stockholders’ Equity 1,627,436 3,136,197
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 4,935,262 $ 5,902,350